Imperial College London

Professor Costanza Emanueli

Faculty of MedicineNational Heart & Lung Institute

Chair in Cardiovascular Science
 
 
 
//

Contact

 

c.emanueli Website

 
 
//

Location

 

434ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Shanmuganathan:2018:10.3389/fphys.2018.01159,
author = {Shanmuganathan, M and Vughs, J and Noseda, M and Emanueli, C},
doi = {10.3389/fphys.2018.01159},
journal = {Frontiers in Physiology},
title = {Exosomes: Basic biology and technological advancements suggesting their potential as ischemic heart disease therapeutics},
url = {http://dx.doi.org/10.3389/fphys.2018.01159},
volume = {9},
year = {2018}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Exosomes are small nano-sized vesicles that deliver biologically active RNA molecules and proteins to recipient cells through binding, fusion or endocytosis. There is emerging evidence that endogenous exosomes released by cardiovascular cells and progenitor cells impact cell survival and proliferation, thus regulating angiogenesis, cardiac protection and repair. These cardioprotective and regenerative traits have the potential to translate in to novel therapeutic options for post-ischaemic cardiac regeneration, thus potentially delaying the progression to ischaemic heart failure. Cellular stressors influence exosomes' secretion and the molecular composition of the exosome cargo, thus impacting on the above processes. Evidences are emerging that loading of proteins and RNAs in the exosomes cargos can be manipulated. Similarly, manipulation of exosomes surface proteins' expression to target exosomes to specific cells and tissues is doable. In addition, nature-inspired synthetic exosomes can be assembled to deliver specific clues to the recipient cells, including proliferative and differentiation stimuli, or shed paracrine signals enabling to reconstructing the heart homeostatic micro-environment. This review will describe exosome biogenesis and emerging evidence of exosome-mediated regenerative cell-to-cell communications and will conclude discussing possibilities of using exosomes to treat ischemic heart disease.
AU - Shanmuganathan,M
AU - Vughs,J
AU - Noseda,M
AU - Emanueli,C
DO - 10.3389/fphys.2018.01159
PY - 2018///
SN - 1664-042X
TI - Exosomes: Basic biology and technological advancements suggesting their potential as ischemic heart disease therapeutics
T2 - Frontiers in Physiology
UR - http://dx.doi.org/10.3389/fphys.2018.01159
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450537000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - http://hdl.handle.net/10044/1/67371
VL - 9
ER -